StockData
Quantum Biopharma Ltd. logo

Quantum Biopharma Ltd. (QNTM) stock

QNTMNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 26, 2026Score 1/30
$1.52−0.07 (-4.40%)

Close on Nov 18, 2026Market cap $5.91MP/E –Yield –

Quantum Biopharma price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Quantum Biopharma's price to book ratio was 0.6× on Feb 27, 2026, against 0.2× a year earlier. Over the last 3 years it ranged from 0.1× to 5.1×, with a median of 1.3×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Feb 27, 20260.6×−0.4
2025Dec 31, 20251.0×+0.8
2024Dec 31, 20240.1×−1.0
2023Dec 29, 20231.2×–

More Quantum Biopharma figures

See a number that looks wrong?